tradingkey.logo

Heartflow Inc

HTFL
29.290USD
+1.550+5.59%
收盤 02/09, 16:00美東報價延遲15分鐘
2.36B總市值
虧損本益比TTM

Heartflow Inc

29.290
+1.550+5.59%

關於 Heartflow Inc 公司

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc簡介

公司代碼HTFL
公司名稱Heartflow Inc
上市日期Aug 08, 2025
CEOFarquhar (John C. M)
員工數量699
證券類型Ordinary Share
年結日Aug 08
公司地址331 E Evelyn Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94041
電話16502411221
網址https://www.heartflow.com/
公司代碼HTFL
上市日期Aug 08, 2025
CEOFarquhar (John C. M)

Heartflow Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United states
42.95M
92.80%
United kingdom
1.52M
3.28%
Japan
1.46M
3.16%
Rest of europe
349.00K
0.75%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 2月8日 週日
更新時間: 2月8日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Bain Capital Life Sciences Investors, LLC
12.27%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
其他
64.11%
持股股東
持股股東
佔比
Bain Capital Life Sciences Investors, LLC
12.27%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
其他
64.11%
股東類型
持股股東
佔比
Investment Advisor
51.67%
Investment Advisor/Hedge Fund
12.52%
Hedge Fund
3.17%
Individual Investor
2.46%
Endowment Fund
0.37%
Bank and Trust
0.32%
Private Equity
0.18%
Sovereign Wealth Fund
0.15%
Pension Fund
0.14%
其他
29.02%

機構持股

更新時間: 1月21日 週三
更新時間: 1月21日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
129
59.51M
43.48%
--
2025Q4
157
60.44M
71.29%
+22.15M
2025Q3
46
45.42M
54.46%
+42.91M

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Bain Capital Life Sciences Investors, LLC
12.45M
14.62%
--
--
Sep 30, 2025
HealthCor Partners Management LP
6.70M
7.86%
--
--
Sep 30, 2025
Wellington Management Company, LLP
4.88M
5.73%
+465.57K
+10.55%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.62M
5.42%
+1.33M
+40.42%
Sep 30, 2025
Capricorn Investment Group LLC
3.92M
4.61%
+3.92M
--
Aug 08, 2025
Hayfin Capital Management LLP
3.64M
4.27%
-1.00
-0.00%
Sep 30, 2025
Baillie Gifford & Co.
3.01M
3.53%
+415.89K
+16.06%
Sep 30, 2025
Schusterman Interests LLC
1.94M
2.28%
+1.94M
--
Sep 30, 2025
The Vanguard Group, Inc.
1.45M
1.7%
+285.27K
+24.45%
Sep 30, 2025
Capital International Investors
1.30M
1.52%
+1.30M
--
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
佔比3.13%
Global X HealthTech ETF
佔比1.75%
Fidelity Blue Chip Growth ETF
佔比0.07%
T Rowe Price Small-Mid Cap ETF
佔比0.06%
iShares Health Innovation Active ETF
佔比0.02%
Schwab U.S. Small-Cap ETF
佔比0.02%
Fidelity Nasdaq Composite Index ETF
佔比0.01%
Schwab U.S. Broad Market ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI